Trial intelligence / Profile preview

ANGELO: Opioid-free vs opioid-based general anesthesia for postoperative nausea and vomiting in robotic bariatric surgery

2025-521047-20-00Phase 4Suspended

Sponsor
IRBLleida
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of magnesium sulfate, lidocaine, dexmedetomidine and ketamine in obesity (2 arms), sponsored by IRBLleida. Primary endpoint: Visual Analog Scale for Nausea (VAS-N). Started Jul 2025; status: suspended.

02

Drugs

magnesium sulfatelidocainedexmedetomidineketamine
03

Conditions

obesity

Beyond the preview

Go deeper on 2025-521047-20-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-521047-20-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call